News | May 19, 2023
Thermo Fisher Scientific expands ImmunoCAP test availability across U.S.
Testing supporting allergy diagnosis now accessible to more people in more communities
Testing supporting allergy diagnosis now accessible to more people in more communities
Concept Medical’s manufacturing arm has reduced its carbon footprint via in-house efficiency improvement programmes & green infrastructure
Bourgoin early development hub broadens offerings for oral solid dose formulations
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
Thermo Fisher and Celltrio bring first-in-kind automation platform to address critical scale-up challenges in biotherapeutics RoboCell cell line automation platform
The acquisition is for an enterprise value of Rs. 218 crores
Thermo Fisher is working closely with large pharmaceutical businesses to develop companion diagnostics in multiple areas such as heart disease, neurosciences and infectious diseases.
Dr. Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.
Subscribe To Our Newsletter & Stay Updated
